Siponimod Chips Away at Progressive MS

Cell - United States
doi 10.1016/j.cell.2019.11.034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

EETing Away at Metastasis

Science-Business eXchange
2012English

Ocrelizumab for Relapsing or Primary Progressive MS

Prescriber
Pharmacology
2018English

Spotlight on Siponimod and Its Potential in the Treatment of Secondary Progressive Multiple Sclerosis: The Evidence to Date

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Rehabilitation in Progressive MS: From Evaluation to Treatment

Swiss Archives of Neurology, Psychiatry and Psychotherapy
PsychiatryClinical PsychologyMental HealthNeurology
2018English

Naive CD4 T-Cell Activation Identifies MS Patients Having Rapid Transition to Progressive MS

Neurology
Neurology
2014English

CHOPing Away at Stress Damage♦

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Reduced Rich-Club Connectivity Is Related to Disability in Primary Progressive MS

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2017English

Absence of Systemic Oxidative Stress and Increased CSF Prostaglandin F2αin Progressive MS

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2016English

Proteome Chips

Genome Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy